SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katamaya K, Kato M, et al. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology 1995; 21:291297.MEDLINE
  • 2
    Martinot Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, et al. Pretreatment serum hepatitis C virus RNA level and hepatitis C virus genotype are the main and independant prognostic factors of sustained response to alfa interferon therapy in chronic hepatitis C. Hepatology 1995; 22:10501056.MEDLINE
  • 3
    Nousbaum JB, Pol S, Nalpas B, Landais P, Bertelot P, Bréchot C. Hepatitis C virus type 1b(II) infection in France and Italy. the collaborative study group. Ann Intern Med 1995; 122:161168.MEDLINE
  • 4
    Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J infect Dis 1995; 171:16071610.MEDLINE
  • 5
    Silini E, Bono F, Cividini A, Cerino A, Maccabrini A, Tinelli C, Bruno S, et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 1995; 22:691695.MEDLINE
  • 6
    Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Tsuji T, Shin S, et al. Efficacy of interferon therapy in chronic hepatitis C depends primilarly on hepatitis C virus RNA level. Hepatology 1995; 22:13511354.MEDLINE
  • 7
    Yokoyama H, Ishii H, Moriya S, Nagata S, Watanabe T, Kamegaya K, Takahashi H, et al. Relationship between hepatitis C virus subtypes and clinical features of liver disease seen in alcoholics. J Hepatol 1995; 22:130134.MEDLINE
  • 8
    Zeuzem S, Franke A, Lee JH, Herrmann G, Rüster B, Roth WK. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests and histology. Hepatology 1996; 24:10031009.MEDLINE
  • 9
    Nalpas B, Thiers V, Pol S, Driss F, Thepot V, Berthelot P, Brechot C. Hepatitis C viremia and antiHCV antibodies in alcoholics. J Hepatol 1992; 14:381384.MEDLINE
  • 10
    Zarski JP, Thelu MA, Moulin C, Rachail M, Seigneurin JM. Interrest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. J Hepatol 1993; 17:1014.MEDLINE
  • 11
    Nishiguchi S, Kuroki T, Yabusako T, Seki S, Kobayashi K, Monna T, Otani S, et al. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991; 14:985989.MEDLINE
  • 12
    Fong TL, Kanel GC, Conrad A, Valinluck B, Charboneau F, Adkins RH. Clinical significance of concomitant hepatitis C virus infection in patients with alcoholic liver disease. Hepatology 1994; 19:554557.MEDLINE
  • 13
    Bagasra O, Kajdacsy-Balla A, Lischner HW, Pomerantz RJ. Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Dis 1993; 167:789797.MEDLINE
  • 14
    Williams GD, Proudfit AH, Quinn EA, Campbell KE. Variation in quantity-frequency measures of alcohol consumption from a general population survey. Workshop on measurement issues in alcohol consumption. Addiction 1994; 89:413420.MEDLINE
  • 15
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431435.MEDLINE
  • 16
    Searle SR. Linear Models for unbalanced data. New York: John Wiley & Sons, Inc., 1987.
  • 17
    Goodnight JH. The new General Linear Models procedure. Proceedings of the first international SAS users' conference. Cary, NC: SAS Institute Inc., 1976.
  • 18
    Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, Inc., 1989.
  • 19
    Draper NR, Smith H. Applied Regression Analysis. New York: John Wiley & Sons, Inc., 1966.
  • 20
    Sawada M, Takada A, Takase S, Takada N. Effects of alcohol on the replication of hepatitis C virus. Alcohol and alcoholism 1993; 28:8590.MEDLINE
  • 21
    Oshita M, Hayashi N, Kashahara A, Hagiwara H, Mita E, Naito M, Katayama H, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994; 20:11151120.MEDLINE
  • 22
    Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic hepatitis: effect of alcohol on hepatitic activity and viral titre. J Hepatol 1996; 25:821826.MEDLINE
  • 23
    Babor TF, Del Boca FK. Just the facts: enhancing measurement of alcohol consumption using self reported methods. In: LittenR, AllenJ, eds. Measuring Alcohol Consumption. Psychosocial and Biochemical Methods. New Jersey: The Humana Press, 1992:319.
  • 24
    Mochida S, Ohnishi K, Matsuo S, Kakihara K, Fujiwara K. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis. Alcohol Clin Exp Res 1996; 20:371A377A.MEDLINE
  • 25
    Brillanti S, Masci C, Siringo S, DiFebo G, Miglioli M, Barbara L. Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol 1991; 13:347350.MEDLINE
  • 26
    Mendenhall CL, Seef L, Diehl AM, Ghosn SJ, French SW, et al. Antibodies to hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. Hepatology 1991; 14:581589.MEDLINE
  • 27
    Wands JR, Blum HE. Hepatitis B and C virus and alcohol induced liver injury. Hepatology 1991; 14:730733.MEDLINE
  • 28
    Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K. A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 1995; 15:300306.MEDLINE
  • 29
    Deny P, Halimi C, Trinchet JC, Munz C, Bianchi A, Mal F, Beaugrand M. Role du virus C dans la genèse des lésions hépatiques observées chez des malades alcooliques atteints de cirrhose. Gastro-Enterol Clin Biol 1994; 18:110114.
  • 30
    Roudot-Thoraval F, Bastie A, Pawlotsky JM, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6664 patients. the Study group for the prevalence and the epidemiology of hepatitis C virus. Hepatology 1997; 26:485490.MEDLINE
  • 31
    Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. for the OBSVIR, METAVIR, CLINIVIR and DOSVIR groups Lancet 1997; 349:825832.
  • 32
    Tong MT, El Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion associated hepatitis. N Engl J Med 1995; 332:14631466.MEDLINE
  • 33
    Fattovich G, Guistina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112:463472.MEDLINE
  • 34
    Muller R. The natural history of hepatitis C: clinical experiences. J Hepatol 1996; 24(suppl 2:5254.MEDLINE
  • 35
    Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJM, Williams R. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13:150157.MEDLINE
  • 36
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. N Engl J Med 1996; 334:815820.MEDLINE
  • 37
    Smith WI, Van Thiel DH, Whiteside T, Janoson B, Magovern J, Puet T, Rabin BS. Altered immunity in male patients with alcoholic liver disease: evidence for defective immune regulation. Alcoholism 1980; 4:199206.
  • 38
    Bagasra O, Howeedy A, Dorio R, Kajdacsy-Balla A. Functional analysis of T-cell subsets in chronic experimental alcoholism. Immunology 1987; 61:6369.MEDLINE
  • 39
    Conference de consensus: Conclusions et recommendations du jury. Gastroenterol Clin Biol 1997; 20:s202s211.
  • 40
    NIH consensus Conference March 1997. Hepatology 1997; 26(suppl 1:2s10s.MEDLINE